OGG Antibodies

Santa Cruz Biotechnology features a diverse variety of OGG Antibodies for the detection and analysis of 8-oxoguanine DNA glycosylase (OGG1), a key enzyme involved in the base excision repair pathway. OGG Antibodies are available for various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). OGG1 plays a critical role in maintaining genomic stability by recognizing and excising oxidatively damaged guanine bases, which can lead to mutations if left unrepaired. The proper functioning of OGG1 is essential for cellular defense against oxidative stress and is implicated in various diseases, including cancer and neurodegenerative disorders. Understanding the activity and regulation of OGG1 is crucial for advancing therapeutic strategies aimed at enhancing DNA repair mechanisms. Research into OGG1 continues to reveal new insights about its role in maintaining cellular health and preventing disease progression. Investigating OGG1 expression patterns helps scientists better understand DNA repair mechanisms and their impact on disease development. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of DNA repair pathways and their implications in human health.